微策生物三位创始人在前台的照片：杨清刚-总经理，杨蓉-董事长，王成超-副总作为POCT最大的细分领域，血糖监测无疑是一块诱惑力极大的蛋糕，单中国市场的规模就已超过50亿元人民币。在雅培、强生、罗氏等外资品牌纷纷前往中国瓜分这块肥肉之时，有一个国产品牌却不走寻常路，将目标瞄准了更广阔的国际市场。公司成立两年便顺利拿到美国FDA、CE、ISO13485、ISO15197:2013等多项欧美市场准入证书，产品远销海外近50个国家。其推出的血糖监测产品更是进入了英国NHS诊疗目录，可在英国NHS体系内自由经销（NHS，即英国国家医疗服务体系）。这家“墙内开花墙外香”的公司便是杭州微策生物技术有限公司...
Micro policy biological three founders in the foreground of photo: Yang Qinggang - general manager, Yang Rong - chairman of the board of directors, as the largest POCT cheng-chao wang - vice President of niche, the blood glucose monitoring is a big lure piece of cake, the scale of the single market in China has more than 5 billion yuan. At abbott, Johnson &johnson, roche and other foreign brands to carve up China in this fat, there is a Chinese brand don't walk unusual road, targeting a broader international market. Company was founded two years smoothly to the FDA, CE, hl-tech corporation, ISO15197:2013 and so on many Europe and the United States market access certification, products are exported to overseas nearly 50 countries. Its blood glucose monitoring products is entered the UK NHS treatment directory, can free distribution within the NHS system (the NHS, Britain's national health service). The "flower wall inside the wall sweet" micro ce biological technology co., LTD. Company is hangzhou...
